Clinical use of temporary percutaneous left ventricular assist devices

Catheterization and Cardiovascular Interventions

Volumn 78, Issue 2, 2011, Pages 304-313

  Froesch, Patric ^a   Martinelli, Michele ^a   Meier, Pascal ^a   Cook, Stéphane ^a   Hullin, Roger ^b   Windecker, Stephan ^a   Mohacsi, Paul ^a   Meier, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

left ventricular support; PCI; shock

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERY DISSECTION; ARTICLE; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FALSE ANEURYSM; FEMALE; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFERIOR CAVA VEIN THROMBOSIS; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR ASSIST DEVICE; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; RESUSCITATION; RETROPERITONEAL HEMATOMA; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; SURVIVAL RATE; TEMPORARY PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HEART-ASSIST DEVICES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SHOCK, CARDIOGENIC; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 79960731302     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22948     Document Type: Article

References (28)

1. Adams KF Jr., Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP,. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-216. (Pubitemid 40348525)
2. Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP,. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 2006; 27: 3011-3017. (Pubitemid 44950446)
3. Garcia-Alvarez A, Arzamendi D, Loma-Osorio P, Kiamco R, Masotti M, Sionis A, Betriu A, Brugada J, Bosch X,. Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention. Am J Cardiol 2009; 103: 1073-1077.
4. Rudiger A, Businger F, Streit M, Schmid ER, Maggiorini M, Follath F,. Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure. Swiss Med Wkly 2009; 139: 110-116.
5. Aragon J, Lee MS, Kar S, Makkar RR,. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65: 346-352. (Pubitemid 40898176)
6. Idelchik GM, Simpson L, Civitello AB, Loyalka P, Gregoric ID, Delgado R III, Kar B,. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant 2008; 27: 106-111.
7. Bruckner BA, Jacob LP, Gregoric ID, Loyalka P, Kar B, Cohn WE, La Francesca S, Radovancevic B, Frazier OH,. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J 2008; 35: 447-450.
8. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P,. The percutaneous ventricle assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011; 57: 688-696.
9. Hermansen SE, Naesheim T, How OJ, Myrmel T,. Circulatory assistance in acute heart failure-Where do we go from here? Scand Cardiovasc J 2009; 43: 211-216.
10. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009; 54: 2430-2434.
11. Vranckx P, Schultz CJ, Valgimigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PW,. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG. Catheter Cardiovasc Interv 2009; 74: 302-310.
12. Ferreiro JL, Gomez-Hospital JA, Cequier AR, Angiolillo DJ, Roura G, et al. Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention. Int J Cardiol 2009; 145: 235-237.
13. Samoukovic G, Rosu C, Giannetti N, Cecere R,. The Impella LP 5.0 as a bridge to long-term circulatory support. Interact Cardiovasc Thorac Surg 2009; 8: 682-683.
14. Windecker S,. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock. Curr Opin Crit Care 2007; 13: 521-527. (Pubitemid 47357452)
15. Cook S, Windecker S,. Percutaneous ventricular assist devices for cardiogenic shock. Curr Heart Fail Rep 2008; 5: 163-169.
16. Koestner SC, Mohacsi PJ, Windecker S, Carrel T, Meier B,. Dispositifs d'assistance cardiaque mécanique. Cardiovasc Med 2008; 11: 346-352.
17. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G,. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001; 104: 2917-2922. (Pubitemid 33139103)
18. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A,. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588.
19. Thiele H, Smalling RW, Schuler GC,. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007; 28: 2057-2063. (Pubitemid 47517433)
20. Hernandez AF, Grab JD, Gammie JS, O'Brien SM, Hammill BG, Rogers JG, Camacho MT, Dullum MK, Ferguson TB, Peterson ED,. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: Data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation 2007; 116: 606-612. (Pubitemid 47364578)
21. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial U.S. experience. JACC Cardiovasc Interv 2009; 2: 91-96.
22. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH,. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009; 28: 827-833.
23. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP,. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J 2009; 30: 459-468.
24. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S,. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: A randomized controlled trial. JAMA 2010; 304: 867-874.
25. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW,. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469 e461- 468.
26. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G,. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26: 1276-1283. (Pubitemid 41435457)
27. Valgimigli M, Steendijk P, Serruys PW, Vranckx P, Boomsma F, et al. Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings. EuroIntervention 2006; 2: 91-100.
28. Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, Moore CH, Loisance DY, El-Banayosy A, Frazier H,. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002, 21: 516-521.